$NTLA, Intellia Therapeutics, Inc. / H1 1. Intellia Therapeutics $NTLA rallied to $35 and then crashed back to $25ish. The developer of CRISPR technology reported earnings that made just $5.6 million in revenue for the quarter. It has $65 million in deferred revenue left. Note that NTLA stock trades at a market cap of $1 billion. 2. Geron Corporation $GERN bottomed at $1.80 and is $3.60. Chase the rip? Short float is 22%. Short squeeze on quad-witching day (Mar 16). 3. Worry not about Micron $MU, a long-time value stock favorite since $25 - $29. PTs are now in the $100+ range. That’s too hopeful. Chase $NVDA instead, though Micron’s valuations are dirt low. 4. $ROKU lockup is expiring soon. Short. 5. With Netflix $NFLX shaming Disney $DIS by market cap, load up on $DIS because the company is fundamentally better. IT owns Star Wars. The content makes recurring revenue. $NFLX debt is getting high and subscribers may quit if prices go up too fast. 6. Wonder if Rite Aid $RAD will stop falling. $2 was supposed to be the post-merger stock price bottom 7. Watch $AMD and wonder why the stock is not rallying alongside $INTC, $NVDA. 8. Let the selling pressure ease on $TEVA, Valeant $VRX 9. In the optical networking space and 3D sensing, watch Lumentum Holdings $LITE, Applied Opto $AAOI perhaps falling to $20 and Finisar $FNSR. What are your moves? Post them below. Share with 800+ members.Further Reading:Boeing PeakedAMD Hit Piece was That Obvious (Proof is here)Which of these Stocks Bottomed?